James West of the Midas Letter published an interview with Aurora Cannabis (TSXV: ACB) (OTC: ACBFF) CEO Terry Booth, discussing some of the factors that differentiate the Canadian licensed producer from its peers. Aurora recently announced more than 12K initial patients added in 2016, so many that the company has had to slow additions recently as it has reached near-term capacity limits. The current license allows for 5.4mm grams per year, but Booth expects that the facility is capable of producing 7mm grams. Booth believes that his company’s relationship with the cannabis community and culture have enabled the initial success:
When I first started looking at this industry, I noticed large lines of divisiveness between producers and the community and the culture, and Aurora has definitely done the job in mending that fence, and we’ve done that through our quality product that we’re producing now, and we’ll do it with the quality product we’re going to produce later.
Terry Booth, Aurora Cannabis CEO
Booth also discussed the company’s expansion project, the 800K sq. ft. Aurora Sky greenhouse. The facility is expected to provide production in late 2017. Booth says that the company will be monitoring the progress of the federal legalization legislation before expanding growth beyond the initial 250-300K sq. ft. area. He also suggested that it will take a while to fully scale up to the annual production capacity of 100 million grams.
Read the transcript or listen to James West’s interview “Aurora Cannabis CEO Terry Booth”: http://www.midasletter.com/midas-letter-financial-radio-podcast/aurora-cannabis-ceo-terry-booth/
